Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
93
datasets available to search
ShareScore release 0.9.0
Dataset results
93 results for “Muscle-invasive bladder cancer;”
Safety and Efficacy Study of MAGE-A3 + AS-15 in Patients With Muscle-invasive Bladder Cancer After Cystectomy
ClinicalTrials.gov study NCT01435356. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT03532451. IPD Sharing: NO. Countries: 1. Publications: 1.
Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT01589094. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT00380029. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy
ClinicalTrials.gov study NCT04660344. IPD Sharing: YES. Countries: 24. Publications: 2.
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866
ClinicalTrials.gov study NCT03924856. IPD Sharing: YES. Countries: 22. Publications: 1.
Adjuvant Nivolumab Following Chemo-Radiation in Localized Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT03171025. IPD Sharing: NO. Countries: 1. Publications: 1.
Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection
ClinicalTrials.gov study NCT05767528. IPD Sharing: NO. Countries: 1. Publications: 15.
Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids
ClinicalTrials.gov study NCT05024734. IPD Sharing: YES. Countries: 1. Publications: 1.
The Role of mRNA-based Urine Test (Xpert Bladder Cancer Monitor) in Predicting the Need for Second Look Biopsy After Transurethral Resection of Non Muscle-invasive Bladder Tumor.
ClinicalTrials.gov study NCT04603612. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Pembrolizumab-Epacadostat Combination to Treat Muscle-invasive Bladder UrotheLIAl canceR: PECULIAR Study
ClinicalTrials.gov study NCT03832673. IPD Sharing: NO. Countries: 1. Publications: 16.
Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt
ClinicalTrials.gov study NCT05776758. IPD Sharing: NO. Countries: 1. Publications: 11.
Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT02722538. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder
ClinicalTrials.gov study NCT02621151. IPD Sharing: YES. Countries: 1. Publications: 0.
Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT06528483. IPD Sharing: NO. Countries: 1. Publications: 11.
Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W
ClinicalTrials.gov study NCT06686381. IPD Sharing: NO. Countries: 1. Publications: 1.
PD-1 Knockout Engineered T Cells for Muscle-invasive Bladder Cancer
ClinicalTrials.gov study NCT02863913. IPD Sharing: UNDECIDED. Countries: 1. Publications: 7.
An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo)
ClinicalTrials.gov study NCT04876313. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer
ClinicalTrials.gov study NCT05226117. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer
ClinicalTrials.gov study NCT03244384. IPD Sharing: Not stated. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.